ATE176154T1 - Verwendung von adenosin zur herstellung eines arzneimittels für kontinuierliche intravenöse infusion an menschlichen patienten - Google Patents

Verwendung von adenosin zur herstellung eines arzneimittels für kontinuierliche intravenöse infusion an menschlichen patienten

Info

Publication number
ATE176154T1
ATE176154T1 AT92201323T AT92201323T ATE176154T1 AT E176154 T1 ATE176154 T1 AT E176154T1 AT 92201323 T AT92201323 T AT 92201323T AT 92201323 T AT92201323 T AT 92201323T AT E176154 T1 ATE176154 T1 AT E176154T1
Authority
AT
Austria
Prior art keywords
adenosine
intravenous infusion
continuous intravenous
preparing
human patients
Prior art date
Application number
AT92201323T
Other languages
English (en)
Inventor
Alf Sollevi
Original Assignee
Item Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25116698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE176154(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Item Dev Ab filed Critical Item Dev Ab
Application granted granted Critical
Publication of ATE176154T1 publication Critical patent/ATE176154T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT92201323T 1985-09-24 1985-10-29 Verwendung von adenosin zur herstellung eines arzneimittels für kontinuierliche intravenöse infusion an menschlichen patienten ATE176154T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77951685A 1985-09-24 1985-09-24

Publications (1)

Publication Number Publication Date
ATE176154T1 true ATE176154T1 (de) 1999-02-15

Family

ID=25116698

Family Applications (2)

Application Number Title Priority Date Filing Date
AT85905544T ATE84419T1 (de) 1985-09-24 1985-10-29 Kontinuierliche intravenoese infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.
AT92201323T ATE176154T1 (de) 1985-09-24 1985-10-29 Verwendung von adenosin zur herstellung eines arzneimittels für kontinuierliche intravenöse infusion an menschlichen patienten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT85905544T ATE84419T1 (de) 1985-09-24 1985-10-29 Kontinuierliche intravenoese infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.

Country Status (9)

Country Link
EP (2) EP0275249B2 (de)
JP (1) JP2535504B2 (de)
AT (2) ATE84419T1 (de)
AU (1) AU613304B2 (de)
CA (1) CA1301652C (de)
DE (4) DE3588205T2 (de)
DK (1) DK253187A (de)
NZ (1) NZ217592A (de)
WO (1) WO1987001593A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002258A1 (en) * 1986-10-06 1988-04-07 The University Of Virginia Alumni Patents Foundati Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US6004945A (en) * 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
US5256398A (en) * 1990-11-08 1993-10-26 Whitby Research, Inc. Composition for determining viability of tissue
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
CN103260670A (zh) 2010-10-15 2013-08-21 塞托弗尔克斯股份有限公司 细胞分离灌流器及其用途
JP2015504318A (ja) 2011-10-14 2015-02-12 サイトフェリックス インコーポレイテッド 心筋機能を向上させるためのカートリッジおよび方法
US20140350553A1 (en) * 2011-11-21 2014-11-27 Denerve Inc. Renal artery ablation catheter and system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845205A (en) * 1970-06-04 1974-10-29 Univ Sydney 2-loweralkylthioadenosines
FR2129833B1 (de) * 1971-03-16 1974-08-02 Cerm Cent Europ Rech Mauvernay
ZA7468B (en) * 1973-01-16 1974-11-27 J Voorhees Compositions and treatment of proliferatave skin diseases with phosphodiesterase inhibitors
DE3133925A1 (de) * 1981-08-27 1983-03-17 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittel zur behandlung von hypertonie
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten

Also Published As

Publication number Publication date
DE3588205D1 (de) 1999-03-11
AU613304B2 (en) 1991-08-01
DE3588205T2 (de) 1999-06-02
DE3586993D1 (de) 1993-02-25
ATE84419T1 (de) 1993-01-15
DE3590855T1 (de) 1988-08-25
EP0275249A1 (de) 1988-07-27
DE3586993T2 (de) 1993-04-29
AU5065585A (en) 1987-04-07
JP2535504B2 (ja) 1996-09-18
DE19975044I2 (de) 2006-02-02
DK253187D0 (da) 1987-05-19
JPS63501497A (ja) 1988-06-09
DE3586993T3 (de) 1998-03-19
EP0275249B2 (de) 1997-12-17
DK253187A (da) 1987-05-19
EP0506205A1 (de) 1992-09-30
WO1987001593A1 (en) 1987-03-26
EP0506205B1 (de) 1999-01-27
NZ217592A (en) 1990-10-26
CA1301652C (en) 1992-05-26
EP0275249B1 (de) 1993-01-13

Similar Documents

Publication Publication Date Title
Bourgeois et al. Characteristics of aortic diastolic pressure decay with application to the continuous monitoring of changes in peripheral vascular resistance
DE3662968D1 (en) Coronary perfusion pump
IT1154319B (it) Analizzatore di anidride carbonica nel flusso espiratorio finale per determinare la pressione parziale dell'anidride carbonica nel sangue arterioso di un paziente
DE60238142D1 (de) Implantierbares system
EP0904012A4 (de) Vorrichtung und verfahren zur blutstrom-messungmittels analyse der biologischen impedanz
SE8506029D0 (sv) Hjert-lungsystem avsett for syresettning av en patients blod
NO175023C (no) Fremgangmåte for in vitro diagnostisering av en innflammasjonssykdom indusert av immunkomplekser som er i omlöp, og fremgangsmåte for fremstilling av dsRNA til den in vitro diagnostisering
ATE176154T1 (de) Verwendung von adenosin zur herstellung eines arzneimittels für kontinuierliche intravenöse infusion an menschlichen patienten
Robinson et al. Regulation of granulopoiesis: positive feed-back
Boarini et al. Comparison of systemic and cerebrovascular effects of isoflurane and halothane
Neill et al. Acute and chronic cardiovascular adjustments to induced anemia in dogs
JOHNSON et al. Effects of isoproterenol and levarterenol on blood flow and oxygen use in hemorrhagic shock
Davis et al. Comparison of changes in blood volume and opacity in dog digital pad and tongue.
Szatmary et al. Haemodynamic and antiischaemic protective effects of intra-aortic balloon counterpulsation in high risk coronary heart patients undergoing percutaneous transluminal coronary angioplasty
Abrahams Intramuscular heparin
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
Slósarska et al. Physiological reactivity of patients with endogenous and neurotic depression.
Dennis Pressure measurements in the lesser circulation of the newborn rabbit
HEWLETT The action of tyramin on the circulation of man
Caceres et al. Computer analysis of the monitoring electrocardiogram
Sadick et al. Hyperemic response to coronary occlusion during a single diastole in conscious dog
Lochner Present Basis of Coronary Therapy
Luchik Ophthalmodynamometric and Ophthalmoscopic Examinations in Patients with Transient Disorders of Cerebral Blood Circulation
Aronova The influence of the chemoreceptors of the sinocarotid region on the coronary circulation
Bushman Instrumentation and control in intensive care

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time